Literature DB >> 2445825

Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro.

K Ljunggren1, E M Fenyö, G Biberfeld, M Jondal.   

Abstract

A method to detect antibodies which mediate antibody-dependent cellular cytotoxicity (ADCC) against HIV-infected target cells was developed. Normal lymphocytes were used as effector cells and different HIV-infected cell lines as target cells. The level of ADCC varied depending on both the effector cell function and the target cell susceptibility. For evaluation of HIV-specific ADCC, the effector function was simultaneously tested against a standard antigen (beta 2 microglobulin), expressed both on infected and uninfected target cells. The HIV-infected monocytoid cell line U937, clone 2, was found to be the most useful target cell in the present system. The detection of antibodies which induce HIV-specific ADCC killing will permit clinical and experimental analysis of the possible importance of such antibodies in protection against HIV-associated disease symptoms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445825     DOI: 10.1016/0022-1759(87)90481-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization.

Authors:  P A Broliden; K Ljunggren; J Hinkula; E Norrby; L Akerblom; B Wahren
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

2.  Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.

Authors:  P A Broliden; L Morfeldt-Månsson; J Rosen; M Jondal; B Wahren
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

3.  Biological significance of the antibody response to HIV antigens expressed on the cell surface.

Authors:  J Goudsmit; K Ljunggren; L Smit; M Jondal; E M Fenyö; M Jonda
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope.

Authors:  M Ohlin; J Hinkula; P A Broliden; R Grunow; C A Borrebaeck; B Wahren
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants.

Authors:  A Mabondzo; P Rouvier; H Raoul; R Le Naour; C Courpotin; F Hervé; F Parnet-Mathieu; G Lasfargues; D Dormont
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

6.  Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates.

Authors:  K Ljunggren; G Biberfeld; M Jondal; E M Fenyö
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

7.  Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.

Authors:  K Ljunggren; A Karlson; E M Fenyö; M Jondal
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

8.  Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.

Authors:  B Böttiger; K Ljunggren; A Karlsson; K Krohn; E M Fenyö; M Jondal; G Biberfeld
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS.

Authors:  M Gerencer; I Valpotić; B Jukić; M Tomasković; I Basić
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Failure of ADCC to predict HIV-associated disease progression or outcome in a haemophiliac cohort.

Authors:  A Dalgleish; A Sinclair; M Steel; D Beatson; C Ludlam; J Habeshaw
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.